Caroline Palomeque's questions to SELLAS Life Sciences Group (SLS) leadership • Q3 2018
Question
Caroline Palomeque of Maxim Group asked about the expected trends in operating expenses for the upcoming year, given the initiation of new clinical trials in the first quarter.
Answer
CFO Gene Mack responded that the company has control over its cash burn and reiterated previous guidance that current cash and equivalents are sufficient to fund operations through at least March 2019. He stated that an update to this financial guidance would be provided during the fourth-quarter report early next year.